证券记录 · 已归档季度
IBRX
ImmunityBio, Inc. · Healthcare · Biotechnology
91被追踪持有人
-1Δ持有人
143.54M持有股份
$283.94M报告持仓市值
+0新建仓位
−1清仓
动量输入(同类管理人):
持有人广度 -1.1% ·
股份流向 +20.7% ·
净新建仓位 -1.1%
· 公式
集中增持:持股数量上升,持有人数量减少
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q4 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 26.24K | $260,014 | n/a | n/a |
| Q2 2026 | 104 | +6 | 153.81M | $1.35B | +10 | −6 |
| Q1 2026 | 103 | +11 | 130.83M | $998.92M | +19 | −8 |
| Q4 2025 | 91 | -1 | 143.54M | $283.94M | n/a | −1 |
| Q3 2025 | 15 | 0 | 77.60M | $190.89M | +2 | −2 |
| Q2 2025 | 12 | +1 | 58.35M | $154.05M | +1 | n/a |
| Q1 2025 | 8 | 0 | 12.96M | $39.01M | +1 | −1 |
| Q4 2024 | 8 | +1 | 14.27M | $36.54M | +2 | −1 |
| Q3 2024 | 6 | 0 | 5.93M | $22.06M | +1 | −1 |
| Q2 2024 | 6 | n/a | 4.42M | $27.95M | n/a | n/a |
持有人 · Q4 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 32.78M | +18.5% | $64.90M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 2 | State Street Global Advisors ✦ (被动) | 16.46M | +45.4% | $32.58M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 3 | Goldman Sachs Group ✦ | 6.15M | +439.4% | $12.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Morgan Stanley ✦ | 5.11M | +51.4% | $10.11M | 0.0% | ▲ Add | 2 | SEC ↗ ×7 |
| 5 | Charles Schwab Investment… | 2.50M | n/a | $4.95M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Barclays Plc | 2.44M | n/a | $4.84M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 7 | Bank Of America Corp /De/ | 2.38M | n/a | $4.72M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 8 | Northern Trust Corp | 2.23M | n/a | $4.42M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 9 | JPMorgan Chase ✦ | 1.22M | -42.4% | $2.42M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 10 | Wells Fargo & Company/Mn | 515.92K | n/a | $1.02M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | UBS AM, a distinct business unit of… | 461.18K | n/a | $913,128 | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 12 | Legal & General Group Plc | 292.47K | n/a | $579,086 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | Blair William & Co/Il | 240.21K | n/a | $475,624 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Raymond James Financial Inc | 211.24K | n/a | $418,245 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Invesco Ltd. | 182.84K | n/a | $362,014 | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 16 | Hsbc Holdings Plc | 172.28K | n/a | $336,812 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | T. Rowe Price ✦ | 158.24K | +30.7% | $314,000 | 0.0% | ▲ Add | 7 | SEC ↗ |
| 18 | Citigroup Inc | 110.51K | n/a | $218,811 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 19 | Franklin Resources Inc | 87.07K | n/a | $172,405 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | State Of Wisconsin Investment Board | 83.54K | n/a | $165,405 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Sei Investments Co | 78.03K | n/a | $154,509 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Commonwealth Equity Services, Llc | 75.78K | n/a | $150,035 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | New York State Common Retirement… | 72.82K | n/a | $144,180 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Ameriprise Financial Inc | 37.79K | n/a | $74,828 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 25 | Pnc Financial Services Group, Inc. | 35.10K | n/a | $69,498 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 26 | Dimensional Fund Advisors Lp | 24.70K | n/a | $48,914 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Mackenzie Financial Corp | 14.42K | n/a | $28,488 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 13.58K | +24.4% | $26,886 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | Mercer Global Advisors Inc /Adv | 13.57K | n/a | $26,863 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Truist Financial Corp | 10.00K | n/a | $19,800 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Jones Financial Companies Lllp | 6.88K | n/a | $13,626 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Us Bancorp \De\ | 2.00K | n/a | $3,960 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 383 持有人, 176.43M 股份, $1.31B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 05
Simon Barry J.
Director · 25.00K 股 · $268,760
Oct 02
Cohen Cheryl
Director · 81.06K 股 · $851,088
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13D/A: Cambridge Equities, LP
24.7% 占股份类别 · 查看 SEC 原始申报文件 ↗
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2025 ·
方法论 ·
通过API获取此数据